Bifidobacterium BLa80 mitigates colitis by altering gut microbiota and alleviating inflammation
Abstract This study was conducted to explore the therapeutic effect of the probiotic Bifidobacterium animalis subsp. lactis BLa80 on inflammatory bowel disease. A model of ulcerative colitis (UC) was induced in C57BL/6 mice by administering of 2.5% dextran sulphate sodium (DSS) for 8 days. After dev...
| Published in: | AMB Express |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2022-06-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13568-022-01411-z |
